BIG PHARMA WATCH: NEW STUDY FINDS DRUG COMPANIES CONTINUING TO HIKE PRICES WITHOUT IMPROVING THEIR DRUGS

01-13-2021 Blog Posts

Unjustified Rx Price Increases Cost American Patients & Health System Billions Big Pharma repeatedly hikes prices on brand name drugs without making any improvements to those medications. That’s the finding of a new analysis conducted by the Institute for Clinical and Economic Review (ICER). The report found that drug companies hiked prices on seven popular […]

BIG PHARMA WATCH: HEADLINES FROM BIG PHARMA’S NEW YEAR PRICE HIKES

01-11-2021 Blog Posts

Second Major Round of Pandemic Price Increases Underscores Urgency for Congress to Hold Drug Companies Accountable In case you missed it, Big Pharma hiked prices on at least 629 prescription drugs in just the first week of the New Year. Brand name giants Pfizer, GlaxoSmithKline and Sanofi were among the companies who increased prices on […]

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

12-31-2020 Blog Posts

Part IV: Escalating Assault on 340B Program for Providers Serving America’s Most Vulnerable Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the ongoing economic impact of the public health crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, prescription […]

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

12-30-2020 Blog Posts

Part III: Angling to Price-Gouge American Public on COVID-19 Treatments Taxpayers Paid to Develop Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the economic impact of the COVID-19 crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, prescription drug […]

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

12-29-2020 Blog Posts

Part II: Gaming the System to Undermine Competition at the Expense of American Patients Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the ongoing economic impact of the public health crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, […]

“DOSE OF REALITY” BIG PHARMA’S YEAR OF BAD BEHAVIOR

12-28-2020 Blog Posts

Part I: Sticking with Price-Hiking “Business-as-Usual” During Pandemic Before the COVID-19 pandemic, more than 58 million Americans struggled to afford their prescription drugs. Now, the ongoing economic impact of the public health crisis continues to leave millions of American workers, families and seniors struggling just to stay afloat. Meanwhile, prescription drug prices continue to rise, […]

TWO BIRDS OF A FEATHER: ASTRAZENECA TO ACQUIRE FELLOW PRICE-GOUGER ALEXION IN MULTI-BILLION DOLLAR DEAL

12-14-2020 Blog Posts

In case you missed it, Big Pharma giant AstraZeneca announced plans to acquire rare disease drug maker Alexion Pharmaceuticals in a $39 billion merger. AstraZeneca, the maker of blockbuster cholesterol medication Crestor, notched nearly $25 billion in revenue in 2019, while Alexion, best known for manufacturing one of the world’s most expensive rare disease medications, […]

REMINDER: REBATE RULE WOULD DO NOTHING TO LOWER DRUG PRICES WHILE HIKING PREMIUMS ON SENIORS AND COSTING TAXPAYERS $200 BILLION

11-16-2020 Blog Posts

Administration Should Abandon Misguided Policy That Rewards Drug Companies’ Price-Gouging and Anti-Competitive Tactics With Massive Bailout On Monday, the Trump Administration took a step toward enacting a misguided policy aimed at eliminating prescription drug rebates in Medicare Part D called the Rebate Rule by sending the measure to the Office of Management and Budget (OMB) […]

BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA & BRISTOL-MYERS SQUIBB

11-5-2020 Blog Posts

Big Pharma Completes Sweep of Beating Wall Street Expectations After 2020 Price Hikes In a final round of third quarter earnings reports, three more Big Pharma giants announced they surpassed earnings expectations after hiking prices on American patients. AbbVie, AstraZeneca and Bristol-Myers Squibb reported sky-high profits after hiking prices on American patients earlier this year. […]

BIG PHARMA EARNINGS WATCH: AMGEN & SANOFI

11-5-2020 Blog Posts

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giants Amgen and Sanofi topped earnings expectations while continuing to hike prices, according to third-quarter earnings reported last week. Amgen The company beat expectations, reporting earnings per share of $4.37 for Q3, better than the estimate of $3.78. The company reported sales of […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.